Isatuximab, pomalidomide and dexamethasone in the treatment of relapsed/refractory multiple myeloma in real clinical practice

Isatuximab, pomalidomide and dexamethasone in the treatment of relapsed/refractory multiple myeloma in real clinical practice

Aim. To evaluate the efficacy and tolerability of the combination of isatuximab, pomalidomide, dexamethasone (IsaPd) in the treatment of relapsed refractory multiple myeloma (RRMM) in a real clinical practice. Materials and methods. The retrospective study included 60 patients (28 men and 32 wome...

Full description

Bibliographic Details
Main Authors: Vadim V. Ptushkin, Yulia В. Kochkareva, Ekaterina А. Sukhova, Eugene A. Nikitin
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2024-12-01
Series:Терапевтический архив
Subjects:
multiple myeloma
overall survival
progression-free survival
isatuximab
pomalidomide
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/636319/pdf

Internet

https://ter-arkhiv.ru/0040-3660/article/viewFile/636319/pdf

Similar Items